戻る
Vincerx Pharma Inc (VINC)価格
VINC 株価推移チャート
VINC 収入
Vincerx Pharma Inc
$0.01
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.01
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.013
始値
$0.0053
当日レンジ
$0.0053 - $0.013
52週レンジ
$0.001 - $3.04
取引高
22
平均取引高
9.1K
1株当たり利益(TTM)
-19.45
配当利回り
--
時価総額
$67.9K
VINCとは何ですか？
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. The company is headquartered in Palo Alto, California and currently employs 12 full-time employees. The company went IPO on 2020-03-10. The firm is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. The company has a next generation bioconjugation platform, called VersAptx. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (positive transcription elongation factor beta (P-TEFb)/CDK9 inhibitor). Its VIP943 is developed using its VersAptx platform and combines an anti-CD123 antibody, a novel legumain-cleavable linker and a kinesin spindle protein inhibitor payload enhanced with CellTrapper technology. Enitociclib is a selective CDK9 inhibitor. Enitociclib effectively blocks P-TEFb-mediated activation of RNA polymerase II, preventing transcription of MCL1 and MYC, proteins associated with poor prognosis in various types of cancer.